www.avient.com Copyright © 2020, Avient Corporation. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. www.avient.com Copyright © 2020, Avient Corporation.

www.avient.com Copyright © 2020, Avient Corporation. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. www.avient.com Copyright © 2020, Avient Corporation.

THE SOLUTION Seeking a way to address these challenges, the manufacturer consulted Avient. In a relatively short time, the Avient team was able to formulate additives that performed well at lower LDRs. Finally, Avient’s willingness and ability to conduct and provide testing results saved the customer time and money.

AVIENT SOLUTION ADDRESSES CRITICAL MANUFACTURING PRODUCTIVITY ISSUES AND DELIVERS OVER $100,000 PER YEAR IN SAVINGS Avient helped the customer calculate costs for the 12-month period. With the Avient material, the manufacturer is expected to save $122,000 per year vs. silicone.

Copyright © 2022, Avient Corporation. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. Avient is committed to the needs of our healthcare customers.

Copyright © 2023, Avient Corporation. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. Avient is committed to the needs of our healthcare customers.

Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources. Each of such adjustments has not yet occurred, are out of Avient’s control and/or cannot be reasonably predicted. For the same reasons, Avient is unable to address the probable significance of the unavailable information.

Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources. For the same reasons, Avient is unable to address the probable significance of the unavailable information. Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M. 2023E (%) 27 78 89 84 82 80 77 88 81 76 70 69 60 54 (6) Av ie nt PP PM FM C C Avient Specialty Other Specialty / MULTIPLE EXPANSION Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $31.18.

Patterson, Chairman, President and Chief Executive Officer, Avient Corporation. As such, we look forward to pursuing other acquisition opportunities and/or repurchasing Avient shares in the open market in the future.” About Avient Avient Corporation (NYSE: AVNT), with expected 2021 revenues of $4.75 billion, provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.

Contact your Avient representative with questions or for additional support. 1.844.4AVIENT www.avient.com Copyright © 2023, Avient Corporation. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. AVIENT MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.